Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population.

Ding, Yin-man; Zhang, Xin-ji; Li, Jing-Ping; Chen, San-san; Zhang, Ren-tao; Tan, Wan-long; Shi, Xiao-Jun

Ding, Yin-man; Zhang, Xin-ji; Li, Jing-Ping; Chen, San-san; Zhang, Ren-tao; Tan, Wan-long; Shi, Xiao-Jun.

Affiliation

Ding YM; Department of Urology, People's Hospital of Xuancheng City, Xuancheng, An hui, China.
Zhang XJ; Department of Urology, Shunde First People's Hospital Affiliated to Southern Medical University, Guangdong, China.
Li JP; Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Chen SS; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhang RT; Department of Urology, People's Hospital of Xuancheng City, Xuancheng, An hui, China.
Tan WL; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shi XJ; Department of Urology, People's Hospital of Xuancheng City, Xuancheng, An hui, China.

Clin Endocrinol (Oxf) ; 83(6): 866-71, 2015 Dec.

Article in En | MEDLINE | ID: mdl-25761129

Subject(s)

Follicle Stimulating Hormone/therapeutic use; Oligospermia/drug therapy; Adult; Double-Blind Method; Female; Humans; Infertility, Male/drug therapy; Male; Pregnancy; Pregnancy Rate; Sperm Count; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligospermia / Follicle Stimulating Hormone Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Female / Humans / Male / Pregnancy Language: En Journal: Clin Endocrinol (Oxf) Year: 2015 Document type: Article Affiliation country: China Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google